(5S)-N-[6-(4-Fluorophenoxy)pyridin-3-yl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxamide

ID: ALA4555151

PubChem CID: 155555948

Max Phase: Preclinical

Molecular Formula: C26H20F2N4O2

Molecular Weight: 458.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1

Standard InChI:  InChI=1S/C26H20F2N4O2/c27-18-5-3-17(4-6-18)25-22-2-1-14-29-23(22)13-15-32(25)26(33)31-20-9-12-24(30-16-20)34-21-10-7-19(28)8-11-21/h1-12,14,16,25H,13,15H2,(H,31,33)/t25-/m0/s1

Standard InChI Key:  LGWODAWKKAYXPR-VWLOTQADSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   28.7695  -22.5965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7683  -23.4161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4764  -23.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4746  -22.1877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1832  -22.5929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1821  -23.4136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8883  -23.8226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6001  -23.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6013  -22.5949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8906  -22.1813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8906  -21.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6004  -20.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6008  -20.1439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8925  -19.7345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1825  -20.1474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1856  -20.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3100  -22.1881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0167  -22.5984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3120  -21.3709    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7254  -22.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4277  -22.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1359  -22.1983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1384  -21.3803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4267  -20.9701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7214  -21.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8465  -20.9724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5538  -21.3818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5512  -22.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2576  -22.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9668  -22.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9650  -21.3773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2580  -20.9717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6746  -22.6071    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.8915  -18.9173    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  6
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 30 33  1  0
 14 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4555151

    ---

Associated Targets(Human)

LHCGR Tclin Luteinizing hormone/Choriogonadotropin receptor (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 458.47Molecular Weight (Monoisotopic): 458.1554AlogP: 5.73#Rotatable Bonds: 4
Polar Surface Area: 67.35Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.03CX Basic pKa: 4.19CX LogP: 4.85CX LogD: 4.85
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -1.64

References

1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G..  (2019)  Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.,  62  (22): [PMID:31670515] [10.1021/acs.jmedchem.9b01382]

Source